Abstract
This paper describes the manifestaton in a child of a new syndrome characterized by unusual, severe, persistent hyponatremia associated with hyposmolarity, euvolemia, inappropriately concentrated urine and elevated natriuresis. This is the fourth case of this syndrome reported to date, and the first to be reported in a neonate. The clinical features resemble those typically observed in patients with inappropriate antidiuretic hormone secretion, although high arginine vasopressin (AVP) levels are lacking. The findings led the authors to hypothesise a nephrogenic syndrome of inappropriate antidiuresis (NSIAD). The previously described R137C gain-of-function mutation was detected by means of mutation analysis of the V2R gene. Our results indicate that NSIAD is already present during the neonatal period and that molecular analysis of the V2R receptor should therefore be carried out, in all newborns with prolonged euvolemic hyponatremia with hypo-osmolarity, high urinary sodium and normal/low or undetectable AVP levels.
This is a preview of subscription content, log in via an institution to check access.
References
Feldman BJ, Rosenthal SM, Vargas GA, Fenwick RG, Huang EA, Matsuda-Abedini M, Lusting RH, Mathias RS, Portale AA, Miller WL, Gitelman SE (2005) Nephrogenic syndrome of inappropriate antidiuresis. N Engl J Med 352:1884–1890
Bartter FC, Schwartz WB (1967) The syndrome of inappropriate secretion of antidiuretic hormone. Am J Med 42:790–806
Baylis PH (2003) The syndrome of inappropriate antidiuretic hormone secretion. Int J Biochem Cell Biol 35:1495–1499
Heng AE, Lautrette A, Deteix P, Souweine B (2006) Syndrome de secretion inappropriée d’hormone antidiurétique: diagnostic et prise en charge. New approaches to detect and manage the syndrome of inappropriate antidiuretic hormone secretion (SIADH). Réanimation 15:490–496
Ellison DH, Berl T (2007) The syndrome of inappropriate antidiuresis. N Engl J Med 356:2064–2072
Rosenthal SM, Gitelman SE, Vargas GA, Feldman BJ (2007) Gain-of-function mutation in the V2 vasopressin receptor. Horm Res 67(Suppl 1):121–125
Bes DF, Mendilaharzu H, Fenwick RG, Arrizurieta E (2007) Hyponatremia resulting from Arginine Vasopressin Receptor 2 gene mutation. Pediatr Nephrol 22:463–466
Decaux G, Vandergheynst F, Bouko Y, Parma J, Vassart G, Vilain C (2007) Nephrogenic syndrome of inappropriate antidiuresis in adults: high phenotypic variability in men and women from a large pedigree. J Am Soc Nephrol 18:606–612
Gitelman SE, Feldman BJ, Rosenthal SM (2006) Nephrogenic syndrome of inappropriate antidiuresis: a novel disorder in water balance in pediatric patients. Am J Med 119(Suppl 1):S54–S58
Verbalis JG, Goldsmith SR, Greenberg A, Schrier RW, Sterns RH (2007) Hyponatremia treatment guidelines 2007: expert panel recommendations. Am J Med 120:S1–S21
Huang EA, Feldman BJ, Schwartz ID, Geller DH, Rosenthal SM, Gitelman SE (2006) Oral urea for the treatment of chronic syndrome of inappropriate antidiuresis in children. J Pediatr 148:128–131
Robertson GL (2006) Regulation of arginine vasopressin in the syndrome of inappropriate antidiuresis. Am J Med 119:S36–S42
Zerbe R, Stropes L, Robertson G (1980) Vasopressin function in the syndrome of inappropriate antidiuresis. Annu Rev Med 31:315–327
Sterns RH, Riggs JE, Schochet SS Jr (1986) Osmotic demyelination syndrome following correction of hyponatremia. N Engl J Med 314:1535–1542
Sterns RH, Cappuccio JD, Silver SM, Cohen EP (1994) Neurologic sequelae after treatment of severe hyponatremia: a multicenter perspective. J Am Soc Nephrol 4:1522–1530
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Marcialis, M.A., Faà, V., Fanos, V. et al. Neonatal onset of nephrogenic syndrome of inappropriate antidiuresis. Pediatr Nephrol 23, 2267–2271 (2008). https://doi.org/10.1007/s00467-008-0913-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-008-0913-z